ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
作者信息
Bakkenist Christopher J, Lee James J, Schmitz John C
机构信息
Department of Radiation Oncology, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA.
Department of Medicine, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA.
出版信息
Clin Colorectal Cancer. 2018 Dec;17(4):255-257. doi: 10.1016/j.clcc.2018.09.001. Epub 2018 Sep 13.
Abstract
摘要
相似文献
1
ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
Clin Colorectal Cancer. 2018 Dec;17(4):255-257. doi: 10.1016/j.clcc.2018.09.001. Epub 2018 Sep 13.
2
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related () Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer.
Cancer Res. 2019 Jun 1;79(11):2933-2946. doi: 10.1158/0008-5472.CAN-18-2807. Epub 2019 Apr 15.
3
Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
Cell Death Dis. 2019 Jul 18;10(8):550. doi: 10.1038/s41419-019-1784-x.
4
Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.
Clin Colorectal Cancer. 2018 Dec;17(4):280-284. doi: 10.1016/j.clcc.2018.05.011. Epub 2018 Jun 8.
5
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
Mol Oncol. 2014 Feb;8(1):83-92. doi: 10.1016/j.molonc.2013.09.004. Epub 2013 Oct 8.
6
53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
J Cancer Res Clin Oncol. 2017 Mar;143(3):419-431. doi: 10.1007/s00432-016-2302-5. Epub 2016 Nov 12.
7
Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines.
Int J Mol Sci. 2019 Jul 24;20(15):3619. doi: 10.3390/ijms20153619.
8
Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.
Clin Cancer Res. 2024 May 15;30(10):2193-2205. doi: 10.1158/1078-0432.CCR-24-0027.
9
Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
Oncogene. 2021 Sep;40(39):5880-5892. doi: 10.1038/s41388-021-01968-2. Epub 2021 Aug 4.
10
Genome-wide single-nucleotide resolution of oxaliplatin-DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines.
J Biol Chem. 2020 May 29;295(22):7584-7594. doi: 10.1074/jbc.RA120.013347. Epub 2020 Apr 16.
引用本文的文献
1
Synergistic effects of complex drug combinations in colorectal cancer cells predicted by logical modelling.
Front Syst Biol. 2023 Feb 27;3:1112831. doi: 10.3389/fsysb.2023.1112831. eCollection 2023.
2
Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database.
Curr Issues Mol Biol. 2025 Jun 6;47(6):430. doi: 10.3390/cimb47060430.
3
ATM is associated with the prognosis of colorectal cancer: a systematic review.
Front Oncol. 2025 Mar 12;15:1470939. doi: 10.3389/fonc.2025.1470939. eCollection 2025.
4
The unique Pt(II)-induced nucleolar stress response and its deviation from DNA damage response pathways.
J Biol Chem. 2024 Nov;300(11):107858. doi: 10.1016/j.jbc.2024.107858. Epub 2024 Oct 5.
5
Induction of resistance to oxaliplatin in cancer by a microRNA/Fem1B/Gli1 pathway.
Am J Cancer Res. 2023 Dec 15;13(12):6011-6025. eCollection 2023.
6
PARP Inhibitors in Colorectal Malignancies: A 2023 Update.
Rev Recent Clin Trials. 2024;19(2):101-108. doi: 10.2174/0115748871260815231116060817.
7
DYRK2 promotes chemosensitivity via p53-mediated apoptosis after DNA damage in colorectal cancer.
Cancer Sci. 2023 Dec;114(12):4558-4570. doi: 10.1111/cas.15973. Epub 2023 Sep 30.
8
Antitumor Activity of lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in Oxaliplatin-Resistant Colorectal Carcinoma.
J Healthc Eng. 2022 Apr 21;2022:9121554. doi: 10.1155/2022/9121554. eCollection 2022.
9
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer.
Cancers (Basel). 2022 Mar 9;14(6):1388. doi: 10.3390/cancers14061388.
10
Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer.
Front Oncol. 2021 Dec 22;11:788809. doi: 10.3389/fonc.2021.788809. eCollection 2021.
本文引用的文献
1
Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.
Clin Colorectal Cancer. 2018 Dec;17(4):280-284. doi: 10.1016/j.clcc.2018.05.011. Epub 2018 Jun 8.
2
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.
Oncotarget. 2017 Dec 5;8(67):110904-110913. doi: 10.18632/oncotarget.22920. eCollection 2017 Dec 19.
3
ATM Mutations in Cancer: Therapeutic Implications.
Mol Cancer Ther. 2016 Aug;15(8):1781-91. doi: 10.1158/1535-7163.MCT-15-0945. Epub 2016 Jul 13.
4
ATM protein is deficient in over 40% of lung adenocarcinomas.
Oncotarget. 2016 Sep 6;7(36):57714-57725. doi: 10.18632/oncotarget.9757.
5
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
J Clin Oncol. 2016 Mar 10;34(8):843-53. doi: 10.1200/JCO.2015.63.0558. Epub 2016 Jan 25.
6
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells.
Blood. 2016 Feb 4;127(5):582-95. doi: 10.1182/blood-2015-05-644872. Epub 2015 Nov 12.
7
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
Oncotarget. 2015 Dec 29;6(42):44289-305. doi: 10.18632/oncotarget.6247.
8
Brd4 shields chromatin from ATM kinase signaling storms.
Sci Signal. 2013 Sep 17;6(293):pe30. doi: 10.1126/scisignal.2004622.
9
Radiation therapy induces the DNA damage response in peripheral blood.
Oncotarget. 2013 Aug;4(8):1143-8. doi: 10.18632/oncotarget.1084.
10
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN.
Oncotarget. 2012 Nov;3(11):1348-55. doi: 10.18632/oncotarget.694.
Zotero 插件